Renato Ivan de Avila
Overview
Explore the profile of Renato Ivan de Avila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
de Souza C, de Andrade D, Jordao J, de Avila R, Borges L, Vaz B, et al.
Oxid Med Cell Longev
. 2018 Feb;
2017:2383157.
PMID: 29422986
Jabuticaba is an exotic fruit native to Brazil that has been arousing medicinal interest. Using chemical (HPLC-PDA, resonance mass spectra, and NMR), electroanalytical (differential pulse voltammetry, radical scavenging assay), and...
22.
Da Mota M, de Carvalho F, de Avila R, de Avila P, Cortez A, Menegatti R, et al.
Life Sci
. 2017 Dec;
201:1-8.
PMID: 29278686
Aims: This study reports the biological properties of LQFM030 in vivo, a molecular simplification of the compound nutlin-1. Main Methods: Ehrlich ascites tumor (EAT)-bearing mice were treated intraperitoneally with LQFM030...
23.
Santos Filho E, da Silva A, de Avila R, Batista A, Marreto R, Lima E, et al.
Life Sci
. 2017 Oct;
193:300-308.
PMID: 28962868
Aims: This study evaluated the mechanisms involved in the chemopreventive effects of a mucoadhesive formulation (FITOPROT), containing curcuminoids from Curcuma longa L. (Zingiberaceae) and Bidens pilosa L. (Asteraceae) extract, against...
24.
de Avila P, de Avila R, Santos Filho E, Cunha Bastos C, Batista A, Mendonca E, et al.
Toxicol Rep
. 2017 Oct;
2:563-573.
PMID: 28962391
Gastrointestinal mucositis induced during cancer treatment is considered a serious dose-limiting side effect of chemotherapy and/or radiotherapy. Frequently, interruption of the cancer treatment due to this pathology leads to a...
25.
de Oliveira Fernandes T, de Avila R, de Moura S, de Almeida Ribeiro G, Naves M, Valadares M
Toxicol Rep
. 2017 Oct;
2:184-193.
PMID: 28962350
(Myrtaceae) is an antioxidant compounds-rich Brazilian fruit popularly known as . In view of this, it was evaluated the hepatoprotective effects of pulp (GPE) or peel/seed (GPSE) hydroalcoholic extracts of...
26.
Cunha Bastos C, de Avila P, Santos Filho E, de Avila R, Batista A, Fonseca S, et al.
Toxicol Rep
. 2017 Sep;
3:279-287.
PMID: 28959548
Introduction: Several studies towards the development of an effective treatment for intestinal mucositis have been reported, since this condition represents a major problem in clinical oncology practice due to cytotoxic...
27.
de Moura S, de Avila R, Brito L, de Oliveira R, de Oliveira G, Pazini F, et al.
Chem Biol Interact
. 2017 Sep;
277:185-194.
PMID: 28890382
Scientific evidences have highlighted 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM021) as a promising anti-inflammatory, analgesic and antinociceptive agent due to its effects on peripheral opioid receptors associated with activation of the nitric oxide/cGMP/K pathway....
28.
Ribeiro E, de Avila R, de Sousa Santos R, Garrote C
GE Port J Gastroenterol
. 2017 Sep;
22(3):93-102.
PMID: 28868385
Introduction: As obesity is currently a major public health problem, bariatric surgery has been widely indicated due to the difficulties involved in the clinical management of obese adults. Objectives: Assess...
29.
Peres-Filho M, Dos Santos A, Leite Nascimento T, de Avila R, Ferreira F, Valadares M, et al.
AAPS PharmSciTech
. 2017 Jul;
19(1):201-212.
PMID: 28681330
Co-encapsulation of anticancer drugs paclitaxel and imatinib in nanocarriers is a promising strategy to optimize cancer treatment. Aiming to combine the cytotoxic and antiangiogenic properties of the drugs, a liposome...
30.
Benfica P, de Avila R, Dos Santos Rodrigues B, Cortez A, Batista A, Gaeti M, et al.
Pharm Biol
. 2017 Jun;
55(1):1899-1908.
PMID: 28644062
Context: 4-Nerolidylcatechol (4-NRC) has showed antitumor potential through apoptosis. However, its apoptotic mechanisms are still unclear, especially in leukemic cells. Objectives: To evaluate the cytotoxic potential of 4-NRC and its...